# SEG Internship Phase 6.10 Gate Report

**Phase:** 6.10 — Evidence Closure Execution Package  
**Mode:** `READ_ONLY GOVERNANCE PREPARATION`  
**Prepared at (UTC):** 2026-08-21T00:00:00Z  
**Decision:** `READY_FOR_EVIDENCE_REVIEW`

## 1. Decision

The minimum documentation package required to begin a controlled evidence-review activity has been prepared. The package is **ready for evidence review**, not evidence-closed and not production-ready.

The decision is limited to handoff readiness for attributable reviewers and authorities. It does not change the Phase 6.9 evidence state, which remains blocked for schema-revalidation readiness until the open and partial gates are closed.

## 2. Package outputs

| Required output | Status | Purpose |
|---|---|---|
| `SEG_INTERNSHIP_FINAL_EVIDENCE_CLOSURE_REGISTER.md` | `CREATED` | Records every required field/gate, current evidence, source, `CLOSED/PARTIAL/OPEN` status, required action, and responsible authority. |
| `SEG_INTERNSHIP_DECISION_OWNER_SIGNOFF_TEMPLATE.md` | `CREATED` | Provides a blank attributable signoff form without inventing approvals. |
| `SEG_INTERNSHIP_MEDICAL_RIGHTS_REVIEW_PACKAGE.md` | `CREATED` | Separates clinical/relevant review from rights review and supplies controlled checklists. |
| `SEG_INTERNSHIP_ARTIFACT_FREEZE_MANIFEST.md` | `CREATED` | Defines the 48 included candidate records, 61 technical exclusions, held-back scope, carried-forward SHA references, and non-final freeze state. |
| `SEG_INTERNSHIP_PHASE_6_10_GATE_REPORT.md` | `CREATED` | Records the package-readiness decision and protected non-actions. |

## 3. Evidence state carried forward

The evidence register records the following conservative state:

| Gate group | Current state | Meaning |
|---|---|---|
| Owner | `PARTIAL` | Internal Decision Owner declaration exists, but per-source linkage and reconciliation remain required. |
| Publisher | `OPEN` | Attributable publisher/release evidence is not supplied. |
| Version | `PARTIAL` | Some version labels exist, but governed release/version reconciliation remains open. |
| SHA linkage | `PARTIAL` | 48 candidate references are carried forward; independent verification remains pending. |
| Rights | `PARTIAL` | Internal handling declaration exists; source/asset-specific rights and display scope remain open. |
| Reviewer | `OPEN` | Attributable reviewer assignments and decisions are not closed. |
| Track | `PARTIAL` | Internship boundary is documented; per-source audience/level/placement remains open. |
| Taxonomy | `PARTIAL` | Pathway and branch contract exists; source-level IDs/versions and attribution remain open. |
| Audit | `OPEN` | Complete append-only evidence chain is not closed. |
| Contract confirmation | `PARTIAL` | Design-only contract recommendations exist; final attributable confirmation remains required. |
| Duplicate decision | `OPEN` | Both duplicate families remain unresolved; no canonical production source is selected. |
| Lineage namespace | `OPEN` | `SRC-0078` and `phone-pediatrics-main` are preserved; alias-versus-distinct semantics remain unresolved. |

## 4. Required evidence-review actions

The evidence-review handoff must obtain attributable owner/publisher/version evidence, independently reconcile SHA-256 values, complete source- and asset-level rights review, assign qualified clinical/relevant and governance reviewers, confirm Internship track/taxonomy placement, assemble append-only audit events, confirm the five domain contracts, complete independent duplicate comparisons, and resolve the lineage namespace decision while preserving both identifiers.

A signed Decision Owner form must identify exact scope, Source IDs, versions, paths, SHA-256 values, authority, limitations, and an append-only audit event. A blank template or unsigned declaration is not an approval.

## 5. Artifact freeze finding

The freeze manifest comparison passed: **48 included candidate rows and 61 excluded technical rows match the governing manifest’s paths and SHA-256 references**. This is a scope-integrity result only. Independent SHA reconciliation, final immutable freeze event, evidence closure, and schema-revalidation authorization remain pending.

## 6. Fail-closed controls

The following actions remain prohibited and unperformed:

- JSON generation or production artifact creation.
- Schema conversion or schema revalidation.
- Database, Prisma, or application modification.
- Content import, activation, publication, or learner display.
- Canonical source selection for duplicate families.
- Resolution or replacement of preserved lineage identifiers.
- Invention of approvals, clinical judgments, rights, publishers, reviewers, taxonomy IDs, or audit events.
- Deletion, renaming, merging, archiving, overwriting, or replacement of original sources.

## 7. Next allowed phase

The next allowed action is a separately authorized **evidence-review execution** using the five prepared reports. Schema revalidation may be considered only after evidence closure, clinical/relevant review, rights review, attributable Decision Owner decisions, duplicate and lineage closure, contract confirmation, and a separate explicit authorization.

## References

[1]: `SEG_INTERNSHIP_FINAL_EVIDENCE_CLOSURE_REGISTER.md` "Final Evidence Closure Register"
[2]: `SEG_INTERNSHIP_DECISION_OWNER_SIGNOFF_TEMPLATE.md` "Decision Owner Signoff Template"
[3]: `SEG_INTERNSHIP_MEDICAL_RIGHTS_REVIEW_PACKAGE.md` "Medical and Rights Review Package"
[4]: `SEG_INTERNSHIP_ARTIFACT_FREEZE_MANIFEST.md` "Artifact Freeze Manifest"
[5]: `SEG_INTERNSHIP_PHASE_6_9_EVIDENCE_CLOSURE_MATRIX.md` "Phase 6.9 Evidence Closure Matrix"
[6]: `SEG_INTERNSHIP_PHASE_6_9_SCHEMA_REVALIDATION_PLAN.md` "Phase 6.9 Schema Revalidation Plan"
[7]: `SEG_INTERNSHIP_REVALIDATION_ARTIFACT_MANIFEST.md` "Controlled Revalidation Artifact Manifest"

<!-- END OF GATE REPORT -->
